Transesophageal Echocardiography: Dysphagia Risk in Acute Stroke (T.E.D.R.A.S. Trial)
TEDRAS
1 other identifier
interventional
34
1 country
1
Brief Summary
The prevalence of dysphagia in acute stroke patients undergoing transesophageal echocardiography (TEE) is unknown. The aim of this study was to assess for the first time whether TEE has a negative influence on swallowing in acute stroke patients.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Jun 2013
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 12, 2013
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 5, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
October 1, 2019
CompletedFirst Submitted
Initial submission to the registry
February 19, 2020
CompletedFirst Posted
Study publicly available on registry
March 10, 2020
CompletedMarch 10, 2020
February 1, 2020
6.2 years
February 19, 2020
March 6, 2020
Conditions
Outcome Measures
Primary Outcomes (9)
Secretion severity
Change in presence and severity of dysphagia examined via FEES and scored by Murray´s Secretions Severity Rating Scale Minimum value: 0 Maximum value: 3 Higher scores mean worse outcome
Intervention group: One day before TEE; Control group: At least three days before TEE
Secretion severity
Change in presence and severity of dysphagia examined via FEES and scored by Murray´s Secretions Severity Rating Scale Minimum value: 0 Maximum value: 3 Higher scores mean worse outcome
Intervention group: 2-4 hours after TEE; Control group: At least two days before TEE
Secretion severity
Change in presence and severity of dysphagia examined via FEES and scored by Murray´s Secretions Severity Rating Scale Minimum value: 0 Maximum value: 3 Higher scores mean worse outcome
Intervention group: 24 hours after TEE; Control group: At least one day before TEE
Dysphagia severity
Change in presence and severity of dysphagia examined via FEES and scored by Rosenbek´s Penetration-Aspiration-Scale Minimum value: 1 Maximum value: 8 Higher scores mean worse outcome
Intervention group: One day before TEE; Control group: At least three days before TEE
Dysphagia severity
Change in presence and severity of dysphagia examined via FEES and scored by Rosenbek´s Penetration-Aspiration-Scale Minimum value: 1 Maximum value: 8 Higher scores mean worse outcome
Intervention group: 2-4 hours after TEE; Control group: At least two days before TEE
Dysphagia severity
Change in presence and severity of dysphagia examined via FEES and scored by Rosenbek´s Penetration-Aspiration-Scale Minimum value: 1 Maximum value: 8 Higher scores mean worse outcome
Intervention group: 24 hours after TEE; Control group: At least one day before TEE
Pharyngeal residue severity
Change in presence and severity of dysphagia examined via FEES and scored by Yale Pharyngeal Residue Severity Rating Scale Minimum value: 1 Maximum value: 5 Higher scores mean worse outcome
Intervention group: One day before TEE; Control group: At least three days before TEE
Pharyngeal residue severity
Change in presence and severity of dysphagia examined via FEES and scored by Yale Pharyngeal Residue Severity Rating Scale Minimum value: 1 Maximum value: 5 Higher scores mean worse outcome
Intervention group: 2-4 hours after TEE; Control group: At least two days before TEE
Pharyngeal residue severity
Change in presence and severity of dysphagia examined via FEES and scored by Yale Pharyngeal Residue Severity Rating Scale Minimum value: 1 Maximum value: 5 Higher scores mean worse outcome
Intervention group: 24 hours after TEE; Control group: At least one day before TEE
Secondary Outcomes (2)
Stroke severity
At the day of admission to hospital and up to 2 weeks after TEE
Degree of disability after stroke
At the day of admission to hospital and up to 2 weeks after TEE
Study Arms (2)
Intervention group
EXPERIMENTALTEE FEES
Control group
ACTIVE COMPARATORFEES
Interventions
Ultrasound of heart chambers via esophagus
Endoscopical swallowing study
Eligibility Criteria
You may qualify if:
- acute stroke (max. 7 days post-onset) as displayed by a cranial computed tomography (CT) or magnetic resonance imaging (MRI)
- written informed consent either by patients themselves or by a legal representative
- indication for TEE
You may not qualify if:
- brain hemorrhage
- either pre-existing neurogenic dysphagia or
- head-and-neck cancer induced dysphagia
- dementia
- aphasia with an impairment in language comprehension
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University Hospital Giessen and Marburg
Giessen, Hesse, 35392, Germany
Related Publications (3)
Barer DH. The natural history and functional consequences of dysphagia after hemispheric stroke. J Neurol Neurosurg Psychiatry. 1989 Feb;52(2):236-41. doi: 10.1136/jnnp.52.2.236.
PMID: 2564884BACKGROUNDHogue CW Jr, Lappas GD, Creswell LL, Ferguson TB Jr, Sample M, Pugh D, Balfe D, Cox JL, Lappas DG. Swallowing dysfunction after cardiac operations. Associated adverse outcomes and risk factors including intraoperative transesophageal echocardiography. J Thorac Cardiovasc Surg. 1995 Aug;110(2):517-22. doi: 10.1016/S0022-5223(95)70249-0.
PMID: 7637370BACKGROUNDHamzic S, Juenemann M, Braun T, Piayda K, Bauer P, Sossalla S, Gerriets T, Khilan H, Butz M, Schramm P, Omar OA. TEDRAS II - transesophageal echocardiography as dysphagia risk in the acute phase of stroke-protocol for a prospective pilot observational trial. Trials. 2025 Oct 27;26(1):445. doi: 10.1186/s13063-025-09065-5.
PMID: 41146308DERIVED
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Tibo Gerriets, MD
Department of Neurology, University Hospital Giessen
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- DIAGNOSTIC
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
February 19, 2020
First Posted
March 10, 2020
Study Start
June 12, 2013
Primary Completion
September 5, 2019
Study Completion
October 1, 2019
Last Updated
March 10, 2020
Record last verified: 2020-02
Data Sharing
- IPD Sharing
- Will not share